Shizuoka University, 836, Ohya, Shizuoka, 422-8529, Japan.
Asian J Psychiatr. 2019 Aug;44:68-69. doi: 10.1016/j.ajp.2019.07.012. Epub 2019 Jul 8.
Sleep-related eating disorder (SRED) is characterized by recurrent episodes of eating during the night, accompanied by partial consciousness and followed by limited recall. Zolpidem is a sedative-hypnotic drug commonly used to treat sleep disorders. Zolpidem reduces sleep latency and increases the total time of sleep. Here, we described a case of a patient with attention-deficit/hyperactivity disorder (ADHD) who suffered from zolpidem-induced SRED. The symptoms disappeared when the use of zolpidem as discontinuation. To the best of our knowledge, this is the first documented case of SRED induced by the use of zolpidem in a patient with ADHD.
睡眠相关进食障碍（SRED）的特征是夜间反复发作的进食行为，伴有部分意识，并伴有有限的回忆。唑吡坦是一种常用的治疗睡眠障碍的镇静催眠药物。唑吡坦可缩短睡眠潜伏期，增加总睡眠时间。在这里，我们描述了一例注意力缺陷多动障碍（ADHD）患者因使用唑吡坦引起的 SRED。当停止使用唑吡坦时，症状消失。据我们所知，这是首例在 ADHD 患者中使用唑吡坦引起 SRED 的病例报告。
